Abdel-Hamid NM[Author] - Search Results

Year	Number of Results
2005	1
2007	1
2008	1
2009	3
2010	2
2011	3
2012	2
2013	2
2014	1
2015	3
2016	4
2018	5
2019	2
2021	5
2022	3

1

Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.

Abdel-Hamid NM, Abass SA. Abdel-Hamid NM, et al. Mol Biol Rep. 2021 Sep;48(9):6525-6538. doi: 10.1007/s11033-021-06635-z. Epub 2021 Aug 11. Mol Biol Rep. 2021. PMID: 34379286 Review.

2

Herbal management of hepatocellular carcinoma through cutting the pathways of the common risk factors.

Abdel-Hamid NM, Abass SA, Mohamed AA, Muneam Hamid D. Abdel-Hamid NM, et al. Biomed Pharmacother. 2018 Nov;107:1246-1258. doi: 10.1016/j.biopha.2018.08.104. Epub 2018 Aug 29. Biomed Pharmacother. 2018. PMID: 30257339 Free PMC article. Review.

3

Identification of Chemo and Radio-Resistant Sub-Population of Stem Cells in Human Cervical Cancer HeLa Cells.

Abdel-Hamid NM, Fathy M, Koike C, Yoshida T, Okabe M, Zho K, Abouzied M, Nikaido T. Abdel-Hamid NM, et al. Cancer Invest. 2021 Sep;39(8):661-674. doi: 10.1080/07357907.2021.1931875. Epub 2021 Jul 8. Cancer Invest. 2021. PMID: 34076552

4

Dantrolene Potentiates the Antineoplastic Effect of Sorafenib in Hepatocellular Carcinoma via Targeting Ca⁺²/PI3K Signaling Pathway.

Zakaria S, Ansary A, Abdel-Hamid NM, El-Shishtawy MM. Zakaria S, et al. Among authors: abdel hamid nm. Curr Mol Pharmacol. 2021;14(5):900-913. doi: 10.2174/1874467214666210126110627. Curr Mol Pharmacol. 2021. PMID: 33573585

5

Targeting the HIF-1α/Cav-1 Pathway with a Chicory Extract/Daidzein Combination Plays a Potential Role in Retarding Hepatocellular Carcinoma.

Zakaria S, Nawaya R, Abdel-Hamid NM, Eldomany RA, El-Shishtawy MM. Zakaria S, et al. Among authors: abdel hamid nm. Curr Cancer Drug Targets. 2021;21(10):881-896. doi: 10.2174/1568009621666210811121120. Curr Cancer Drug Targets. 2021. PMID: 34382525

6

A survey on herbal management of hepatocellular carcinoma.

Abdel-Hamid NM, Nazmy MH, Mahmoud AW, Fawzy MA, Youssof M. Abdel-Hamid NM, et al. World J Hepatol. 2011 Jul 27;3(7):175-83. doi: 10.4254/wjh.v3.i7.175. World J Hepatol. 2011. PMID: 21866249 Free PMC article.

7

Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinoma.

Abdel-Hamid NM, Abdullah AH. Abdel-Hamid NM, et al. Clin Exp Med. 2019 Feb;19(1):115-120. doi: 10.1007/s10238-018-0537-y. Epub 2018 Nov 20. Clin Exp Med. 2019. PMID: 30460419

8

Expression of thioredoxin and glutaredoxin in experimental hepatocellular carcinoma-Relevance for prognostic and diagnostic evaluation.

Abdel-Hamid NM, Mahmoud TK, Abass SA, El-Shishtawy MM. Abdel-Hamid NM, et al. Pathophysiology. 2018 Dec;25(4):433-438. doi: 10.1016/j.pathophys.2018.08.008. Epub 2018 Sep 12. Pathophysiology. 2018. PMID: 30224102

9

Serum serotonin as unexpected potential marker for staging of experimental hepatocellular carcinoma.

Abdel-Hamid NM, Shehata DE, Abdel-Ghany AA, Ragaa A, Wahid A. Abdel-Hamid NM, et al. Biomed Pharmacother. 2016 Oct;83:407-411. doi: 10.1016/j.biopha.2016.07.005. Epub 2016 Jul 15. Biomed Pharmacother. 2016. PMID: 27424322

10

Chemosensitizing effect of Alpinia officinarum rhizome extract in cisplatin-treated rats with hepatocellular carcinoma.

Abass SA, Abdel-Hamid NM, Abouzed TK, El-Shishtawy MM. Abass SA, et al. Among authors: abdel hamid nm. Biomed Pharmacother. 2018 May;101:710-718. doi: 10.1016/j.biopha.2018.02.128. Epub 2018 Mar 22. Biomed Pharmacother. 2018. PMID: 29524879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results